Search Results 161-170 of 11353 for ���������������������������:za33���24������ ������������������������ ������

  1. MAYO CLINIC RADIO

    Lift off with us Saturday, May 24, when we have out of this world researchers on Mayo Clinic Radio! Abba Zubair M.D., Ph.D., from Mayo Clinic in Florida, ...

  2. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Study ACT16970 consists of 2 parts (A and B) as follows: Part A is a 24 week, double blind, placebo controlled part, preceded by a screening period of up to ...

  3. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  4. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  5. Tricuspid valve repair and tricuspid valve replacement - Doctors & Departments - Mayo Clinic

    These heart surgeries treat tricuspid valve regurgitation and stenosis and Ebstein anomaly, a type of congenital heart defect. Learn how they're done.

  6. Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma - Mayo Clinic

    Rochester, Minnesota: 24-011608; Scottsdale/Phoenix, Arizona: 24-011608. NCT ID: NCT06608927. Sponsor Protocol Number: PRISM-1. About this study. The purpose ...

  7. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  8. Oncology (Medical) - Clinical trials - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  9. Publications - Yujie Zhao, M.D., Ph.D. - Mayo Clinic

    2023 Dec; 24 (8):689-695.e1 Epub 2023 Sept 17. View PubMed; Sacchi de Camargo Correia G, Pai T, Li S, Connor D, Zhao Y, Lou Y, Manochakian R. Immune-Related ...

  10. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-011889; Jacksonville, Florida: 24-011889. NCT ID: NCT06158841. Sponsor Protocol Number: M22-574. About this study. The purpose ...